FDA Approved: ICATIBANT — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ICATIBANT submitted by Teva Pharmaceuticals USA, Inc. This action relates to a supplemental filing for ICATIBANT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• ICATIBANT (icatibant)

Snippet

SUPPL AP for ICATIBANT (ICATIBANT)